Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO).

@article{Hetland2005RoutineDR,
  title={Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO).},
  author={Merete Lund Hetland and Janne Unkerskov and Tomaas Ravn and Morten Friis and Ulrik Tarp and Lis Smedegaard Andersen and Aleksandra Petri and Haris Nazir Khan and Doris Irene Stenver and Annette Hansen and Mikkel Ostergaard},
  journal={Scandinavian journal of rheumatology},
  year={2005},
  volume={34 1},
  pages={40-4}
}
OBJECTIVE To present from the Danish Database for Biological Therapies in Rheumatology (DANBIO) the frequencies and types of adverse events as well as risk factors during treatment with biological agents in clinical practice. METHODS Adverse events during the first 2 years of clinical use of biological agents in Denmark were reported to the nationwide… CONTINUE READING